Zhang HY - Search Results

1

Structural and energetic analyses of SNPs in drug targets and implications for drug therapy.

Sun HY, Ji FQ, Fu LY, Wang ZY, Zhang HY. Sun HY, et al. Among authors: zhang hy. J Chem Inf Model. 2013 Dec 23;53(12):3343-51. doi: 10.1021/ci400457v. Epub 2013 Dec 10. J Chem Inf Model. 2013. PMID: 24304102

2

Do biologically relevant compounds have more chance to be drugs?

Kong DX, Ren W, Lü W, Zhang HY. Kong DX, et al. Among authors: zhang hy. J Chem Inf Model. 2009 Oct;49(10):2376-81. doi: 10.1021/ci900229c. J Chem Inf Model. 2009. PMID: 19852515

3

Exploring the common molecular basis for the universal DNA mutation bias: revival of Löwdin mutation model.

Fu LY, Wang GZ, Ma BG, Zhang HY. Fu LY, et al. Among authors: zhang hy. Biochem Biophys Res Commun. 2011 Jun 10;409(3):367-71. doi: 10.1016/j.bbrc.2011.05.017. Epub 2011 May 10. Biochem Biophys Res Commun. 2011. PMID: 21586276 Review.

4

Can medical genetics and evolutionary biology inspire drug target identification?

Wang ZY, Fu LY, Zhang HY. Wang ZY, et al. Among authors: zhang hy. Trends Mol Med. 2012 Feb;18(2):69-71. doi: 10.1016/j.molmed.2011.11.004. Epub 2011 Dec 13. Trends Mol Med. 2012. PMID: 22172275

5

Oxidative DNA damage is important to the evolution of antibiotic resistance: evidence of mutation bias and its medicinal implications.

Wang ZY, Xiong M, Fu LY, Zhang HY. Wang ZY, et al. Among authors: zhang hy. J Biomol Struct Dyn. 2013;31(7):729-33. doi: 10.1080/07391102.2012.709457. Epub 2012 Aug 22. J Biomol Struct Dyn. 2013. PMID: 22908856

6

The sequencing bias relaxed characteristics of Hi-C derived data and implications for chromatin 3D modeling.

Peng C, Fu LY, Dong PF, Deng ZL, Li JX, Wang XT, Zhang HY. Peng C, et al. Among authors: zhang hy. Nucleic Acids Res. 2013 Oct;41(19):e183. doi: 10.1093/nar/gkt745. Epub 2013 Aug 21. Nucleic Acids Res. 2013. PMID: 23965308 Free PMC article.

7

Metabolite concentration as a criterion for antibacterial discovery.

Wang ZY, Zhu Q, Zhang HY. Wang ZY, et al. Among authors: zhang hy. Curr Comput Aided Drug Des. 2013 Sep;9(3):412-6. doi: 10.2174/15734099113099990030. Curr Comput Aided Drug Des. 2013. PMID: 24010936 Review.

8

Exploring the biologically relevant chemical space for drug discovery.

Deng ZL, Du CX, Li X, Hu B, Kuang ZK, Wang R, Feng SY, Zhang HY, Kong DX. Deng ZL, et al. Among authors: zhang hy. J Chem Inf Model. 2013 Nov 25;53(11):2820-8. doi: 10.1021/ci400432a. Epub 2013 Nov 1. J Chem Inf Model. 2013. PMID: 24125686

9

Medical genetic inspirations for anticancer drug repurposing.

Wang ZY, Quan Y, Zhang HY. Wang ZY, et al. Among authors: zhang hy. Trends Pharmacol Sci. 2014 Jan;35(1):1-3. doi: 10.1016/j.tips.2013.11.002. Epub 2013 Dec 4. Trends Pharmacol Sci. 2014. PMID: 24315157 No abstract available.

10

Rational drug repositioning by medical genetics.

Wang ZY, Zhang HY. Wang ZY, et al. Among authors: zhang hy. Nat Biotechnol. 2013 Dec;31(12):1080-2. doi: 10.1038/nbt.2758. Nat Biotechnol. 2013. PMID: 24316641 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,971 results

Search Page

Filters